Manapad, Alhadz A.

HRN: 23-76-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/28/2023
11/04/2023
IVT
42mg
Q24
Thickly MSAF; PSNB
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: